Structure Therapeutics Inc - ADR
GPCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.73B
Close$
$13.40
71.7% downside
Current Fair Value
71.7% downsideOvervalued by 71.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.73 Billion |
|---|---|
| Enterprise Value | $2.46 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.4 |
| Beta | -1.51 |
| Outstanding Shares | 72,652,333 |
Return
| Return on Equity | -15.86% |
|---|---|
| Return on Assets | -15.07% |
| Return on Invested Capital | -17.36% |
Valuation & Multiples
| P/E Ratio | -15.63 |
|---|---|
| PEG | -21.85 |
| Price to Sales | - |
| Price to Book Ratio | 2.63 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -10.43 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$45.45 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6282▲ 35.96% |
|---|---|
| Total Calls | 534,600▼ 34.31% |
| Total Puts | 335,823▲ 53.62% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.10%▼ 19.02% |
|---|---|
| Total Invested | $3.22B▼ 29.66% |
| Investors Holding | 209▼ 1.00% |
ESG Score
No data